Literature DB >> 7083131

Cell kinetics in acute leukemia: a critical reevaluation based on new data.

W Hiddemann, T Büchner, M Andreeff, B Wörmann, M R Melamed, B D Clarkson.   

Abstract

The current study was undertaken to compare biopsy and aspiration sampling techniques for reliable cell kinetic analysis in acute leukemia and to reevaluate the clinical significance of cell kinetic data in this disease. Ad 1: One hundred forty-three paired simultaneously taken marrow aspirates and Jamshidi biopsies from 61 patients with acute nonlymphocytic leukemia (ANLL) were compared by means of flow cytometry (FCM) for cellular DNA and RNA measurements, autoradiography for 3H-TdR labeling index and liquid scintillation counting for 3H-TdR uptake. Aspirates were found unreliable for pretreatment evaluation and for monitoring of drug induced cell kinetic perturbations due to contamination with peripheral blood. Aspiration should, therefore, be replaced by marrow biopsy which provides reliable sampling of bone marrow for cell kinetic studies. Ad 2: FCM S-phase index determined from biopsy material was not found predictive for therapeutic response in 43 patients with ANLL treated with two different induction regimens. In one of the two protocols, changes in FCM S-phase index after 48 hours continuous infusion of cytosine arabinoside correlated significantly with clinical response and nonresponse, respectively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083131     DOI: 10.1002/1097-0142(19820715)50:2<250::aid-cncr2820500215>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.

Authors:  H M Kantarjian; B Barlogie; M J Keating; R R Hall; T L Smith; K B McCredie; E J Freireich
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

2.  Assessment of proliferative activity in leukaemic bone marrow using the monoclonal antibody Ki-67.

Authors:  D M White; A G Smith; J L Smith
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

3.  Flow cytometry DNA measurement for prediction of effect of therapy in acute leukemia.

Authors:  R X Zhang; E G Yao
Journal:  J Tongji Med Univ       Date:  1990

4.  Analysis of the cellular DNA and RNA content in acute leukemias by flow cytometry.

Authors:  W Hiddemann; B Wörmann; D Messerer; R Springefeld; T Büchner
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 5.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

6.  Bone marrow cells in the DNA-synthesis-phase in the myelodysplastic syndrome and lymphome.

Authors:  A M Wenthzel; A Porwit; K Lindahl; S Widell; P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

7.  Cell kinetics after high dose cytosine arabinoside in patients with acute myelocytic leukemia.

Authors:  L P Colly; W G Peters; M W Arentsen-Honders; R Willemze
Journal:  Blut       Date:  1990-02

8.  Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics.

Authors:  P P Brons; C Haanen; J B Boezeman; P Muus; R S Holdrinet; A H Pennings; H M Wessels; T de Witte
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

9.  Cell kinetics in acute lymphoblastic leukaemia: comparative analysis between adults and children.

Authors:  M Ffrench; J P Magaud; A M Manel; P Adeleine; Y Devaux; D Fiere; N Philippe; G Souillet; P A Bryon
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.